Both in Pharmaceuticals
Cue Biopharma vs Foghorn Therapeutics
Over the past year CUE returned −8.3% and FHTX returned −40.5%; their daily moves had a correlation of -0.03.
CUE −8.3% FHTX −40.5%Growth of $1, one year, split-adjusted
| Metric | CUE | FHTX |
|---|---|---|
| Price | $19.84 | $2.10 |
| Market cap | $144.1M | $124.7M |
| Today | −4.89% | −1.41% |
| 1 month | −14.3% | +6.6% |
| 6 months | −41.6% | −55.1% |
| Year to date | +116.5% | −61.1% |
| 1 year | −7.8% | −50.1% |
| Revenue growth (YoY) | +166.7% | +112.7% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1943.2% | −44.7% |
| P/E (TTM) | — | — |
| Price / sales | 3.8× | 3.4× |
| Net cash | $16.4M | $167.6M |
| Dividend yield | — | — |
| Volatility (60d) | 137.7% | 98.0% |
| Short % of float | 12.2% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).